Orange 21 Inc.'s net sales for the third quarter of 2005 increased 8.4% to $10.8 million compared to $10.0 million in the third quarter of 2004, meeting the high end of the Company's previously announced estimate. The Company reported net income for the third quarter of 2005 of approximately $192,000, compared to net income of approximately $517,000 in the third quarter of 2004. Earnings per diluted share for the third quarter were $0.02 on approximately 8.3 million weighted average shares outstanding compared to $0.10 per share on approximately 5.1 million weighted average shares outstanding in the same period a year ago.
Cash, cash equivalents, and short term investments at September 30, 2005, totaled approximately $10.8 million.
“Although our earnings for the third quarter were less than expected we are pleased with our year to date increase in revenue of approximately 24%. While our third quarter results were adversely impacted by delays in manufacturing, lower than expected sales in our E Eyewear product line, changes to several international distributors, and continued weakness in the U.S. dollar relative to the Euro, we are excited about the continuing global sales growth in the brand,” said Barry Buchholtz, Chief Executive Officer. “We have experienced growing pains during our first year as a public company, but despite these near-term challenges, we remain optimistic about 2006 and beyond, as we believe we are taking the right strategic initiatives to achieve our sales growth and margin improvement goals. Our core brand is well positioned, and we believe our popular existing styles combined with the many new products we've announced will drive sales momentum.”
2005 Outlook
The Company previously announced 2005 annual revenue guidance in the range of $41.5 – $42.5 million and fully diluted earnings per share in the range of $0.05 – $0.09. The guidance includes an estimated $0.02 of dilution from the previously announced acquisition of Orange 21's eyewear manufacturer LEM, and an estimated $0.01 to $0.02 reduction attributable to the costs of the Oakley and Class Action law suits.
Orange 21 Inc. and Subsidiaries Consolidated Statements of Operations (unaudited) Three months ended Nine months ended September 30, September 30, ------------------------ ------------------------- 2004 2005 2004 2005 ----------- ------------ ------------ ------------ Net sales $9,977,364 $10,819,773 $24,028,325 $29,707,956 Cost of sales 4,619,500 5,310,534 10,930,375 14,494,701 ----------- ------------ ------------ ------------ Gross Profit 5,357,864 5,509,239 13,097,950 15,213,255 ----------- ------------ ------------ ------------ Operating expenses: Sales and marketing 3,048,848 3,462,546 7,875,932 9,381,103 General and administrative 1,069,485 1,368,080 3,242,121 4,223,149 Shipping and warehousing 315,642 334,917 670,313 924,508 Research and development 96,474 160,562 283,679 475,018 ----------- ------------ ------------ ------------ Total operating expenses 4,530,449 5,326,105 12,072,045 15,003,778 ----------- ------------ ------------ ------------ Income from operations 827,415 183,134 1,025,905 209,477 Other income (expense) Interest (expense) income - net (90,680) 85,632 (324,930) 236,045 Foreign currency transaction gain 242,884 165,933 97,170 66,345 Other income (expense) - net 48,747 4,704 48,572 (7,917) ----------- ------------ ------------ ------------ Total other income (expense) 200,951 256,269 (179,188) 294,473 ----------- ------------ ------------ ------------ Income before income taxes 1,028,366 439,403 846,717 503,950 Income tax provision 511,442 247,293 761,401 444,451 ----------- ------------ ------------ ------------ Net income $516,924 $192,110 $85,316 $59,499 =========== ============ ============ ============ Net earnings per common share Basic $0.11 $0.02 $0.02 $0.01 =========== ============ ============ ============ Diluted $0.10 $0.02 $0.02 $0.01 =========== ============ ============ ============ Weighted average common shares outstanding Basic 4,898,246 8,026,502 4,570,556 8,014,352 =========== ============ ============ ============ Diluted 5,073,466 8,339,792 4,745,788 8,407,376 =========== ============ ============ ============